18 Nov 2019
Will PARTNER-3 and Evolut low-risk trials change my practice?
Chairpersons:
D. Capodanno, D. Hildick-Smith
Summary
Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.
Learning Objectives
- To gain an in-depth understanding of the trials comparing TAVI and SAVR in patients at low surgical risk
- To reflect how these trials will affect your day-to-day clinical practice
- To appreciate the limitations of the trials and key remaining questions
